PL1: Plenary Session and Formal Opening -- Henry N. Wagner, Jr., MD Lectureship

Sunday, June 11
8:00 AM–9:30 AM

Location: Four Seasons Ballroom (Colorado Convention Center)

Education: Plenary

CME: 1.00
ACPE: 1.00 [0210-0000-17-295-L04-P ]
VOICE A+: 1.00
CAMPEP: 1.00

Educational Objectives
Upon completion of this activity, the participant will be able to:
1. Discuss the future of nuclear medicine, molecular imaging and therapy.
2. Review the development of theranostics within molecular nuclear medicine over the last two decades with a focus on neuroendocrine tumors and prostate cancer.
3. Examine the origin and meaning of theranostics and determine the importance within the concept of personalized and precision medicine.


8:00 AM - 8:15 AM
Welcome Remarks
Satoshi Minoshima, MD, PhD; Sally W. Schwarz, MS, RPh, BCNP, FAPhA; Sara G. Johnson, MBA,CNMT,NCT,FSNMMIT; Eleanor S. Mantel, CNMT,RT(N) FSNMMI-TS

8:15 AM - 8:20 AM
Annual Meeting Preview
Satoshi Minoshima, MD, PhD

8:20 AM - 8:30 AM
2017 Annual Meeting Highlight Country Update -- Germany
Bernd Joachim Krause, MD

8:30 AM - 8:35 AM
Announcement of the SAFTIE (Scanning to Assess for Traumatic Injury and Encephalopathy) Study
Julian Bailes, MD; Michael J. Savage

8:35 AM - 8:50 AM
Imaging With a Purpose: The Future of Nuclear Medicine, Molecular Imaging and Therapy
Johannes Czernin, MD

8:50 AM - 9:15 AM
Henry N. Wagner, Jr., MD Lectureship: Theranostics - Looking Back and Moving Forward
Richard P. Baum, MD, PhD

9:15 AM - 9:20 AM
Presentation of the ERF-SNMMI Paul C. Aebersold Award: Martin Pomper, MD, PhD
Michael R. Zalutsky, PhD

9:20 AM - 9:25 AM
Presentation of the Georg Charles de Hevesy Award: Joanna Fowler, PhD
Nora D. Volkow, MD

9:25 AM - 9:30 AM
Sally W. Schwarz, MS, RPh, BCNP, FAPhA